While no details were provided, Walgreen Co. (NYSE: WAG) and Express Scripts Holding Co. (NASDAQ: ESRX) this morning announced a new multiyear deal that will once again add Walgreens stores to the pharmacy network served by Express Scripts. The two companies dropped complaints against each other in early June, saying, “These dismissals have no impact on the parties’ ability or inability to come to terms on a pharmacy agreement.”
The deal gives Walgreen access to the 150 million members of the Express Scripts pharmacy benefits management network, by far the largest network in the country. In June Walgreen added a multiyear agreement with OptumRx, a division of Unitedhealth Group Inc. (NYSE: UNH), that gave OptumRx’s 14 million members access to Walgreen’s 7,800 retail stores.
Walgreen shares are up about 14% in premarket trading, at $35.25, in a 52-week range of $28.53 to $42.36.
Shares of Express Scripts are up about 3.3% at $59.60, a new 52-week high if it holds. The current 52-week range is $34.47 to $58.98.
Paul Ausick
The #1 Thing to Do Before You Claim Social Security (Sponsor)
Choosing the right (or wrong) time to claim Social Security can dramatically change your retirement. So, before making one of the biggest decisions of your financial life, it’s a smart idea to get an extra set of eyes on your complete financial situation.
A financial advisor can help you decide the right Social Security option for you and your family. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you.
Click here to match with up to 3 financial pros who would be excited to help you optimize your Social Security outcomes.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
